All Articles

This Startup Wants To Revolutionize The Inhaler

December 5, 2023
x min read

There might be a new way to deliver dry powder drugs to patients. And it’s made from an unexpected material: cardboard.

What’s happening:

  • Scotland based drug delivery device developer 1nhaler has raised €2M in a seed round
  • The round was led by Archangels and also included participation from British Business Investments

The big idea:

  • 1nhaler has developed a sustainable single use medical inhaler capable of delivering multiple types of dry powder drugs to patients
  • Their inhaler is made entirely of cardboard, is completely recyclable and is able to lie completely flat while it is being stored
  • 1nhaler has a patented drug delivery mechanism that features a breathable membrane which can be uniquely tailored depending on the specific type of medication being used

Why it matters:

  • Inhalable medicine is currently used to treat conditions such as asthma and epilepsy but delivery devices are relatively limited, largely due to issues with performance and high production costs
  • Traditional single use inhalers are expensive to produce due to their size and commonly being made entirely out of plastic

The intrigue:

  • Dr. Yusuf Hamaid, who is the non-executive Chairman of Indian pharmaceutical giant Cipla, also participated in the seed round

Discover what’s next. The world’s biggest ideas, disruptive trends, most exciting early stage companies and groundbreaking entrepreneurs.

By clicking Subscribe you're confirming that you agree with our Privacy Policy.
Thanks for subscribing!
Keep an eye out for a welcome email shortly.
Oops! Something went wrong while submitting the form.